FMR1 and fragile X syndrome: In the context of FXS, high construct validity would either require the insertion of an expanded CGG repeat under FMR1’s endogenous promoter to cause its hypermethylation and inactivation or destabilization of the endogenous repeat tract perhaps through removal of the ‘G’ interruption/s to permit in situ CGG repeat expansion.